Analysis of Heterozygous BRCA1 5382ins Founder Mutation in a Cohort of Egyptian Breast Cancer Female Patients Using Pyrosequencing Technique

Document Type : Research Articles

Authors

1 Department of Chemical Pathology, Medical Research Institute, Alexandria University, Egypt.

2 Department of Experimental and Clinical Surgery, Medical Research Institute, Alexandria University, Egypt.

3 M.B.B.Ch, Faculty of Medicine, Alexandria University, Egypt.

4 Department of Chemical and Clinical Pathology, Faculty of Medicine, Alexandria University, Egypt.

Abstract

Background: Up to half of the heritable mutations in breast cancer (BC) are attributed to BRCA1 and BRCA2 genes. The mutation prevalence is variable based on ethnicity and may be influenced by founder mutations. The aim of this pilot study is to determine for the first time, the prevalence of BRCA1 5382insC founder mutation in a cohort of Egyptian familial breast cancer patients (FBC). Methods: Female patients were selected to have familial type of breast cancer. Twenty healthy females were included as a control group. Peripheral blood samples were withdrawn from all studied females and were analyzed for BRCA1 5382insC founder mutation detection using pyrosequencing technique. Results: Eighty Egyptian FBC females were eligible to be enrolled in the study with a mean age of 48.31 ± 10.97years.We found a BRCA1 5382insC mutation carrier frequency of 5% of total studied FBC patients (4 out of 80 patients) with 95% confidence interval (1.61-12.99). There was a high statistical significant difference between carriers and non-carriers concerning the number of affected family members by BC, (p=0.001).  Conclusion: BRCA1 5382insC founder mutation is not uncommon among Egyptian FBC females. The carrier frequency is comparable to that reported worldwide; however it is lower than those from previous Egyptian studies using different molecular techniques. The strong association between the mutation and the number of affected family members suggest wider screening of the mutation among high risk families using the reliable pyrosequencing technique.

Keywords

Main Subjects

Asian Pacific Journal of Cancer Prevention
Volume 21, Issue 2
February 2020
Pages 431-438

Files

History

  • Receive Date: 10 August 2019
  • Revise Date: 15 November 2019
  • Accept Date: 01 December 2019

Share

How to cite

Statistics